Global Antimicrobial Peptides Market Analysis By Type (Cationic Peptides, Linear Peptides, Cyclic Peptides, Alpha-Helical Peptides, Beta-Sheet Peptides, Other Peptides), By Source (Natural Sources, Synthetic Peptides, Recombinant Peptides, Engineered Peptides), By Application (Healthcare & Therapeutics, Agriculture & Animal Health, Cosmetics & Personal Care, Food & Beverages, Veterinary Medicine), By Route of Administration (Topical, Oral, Injectables, Inhalation, Others), By End-User (Pharmaceuticals, Biotechnology, Veterinary Clinics, Others) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Oct 2025
- Report ID: 163297
- Number of Pages: 229
- Format:
-
keyboard_arrow_up
-
-
- AstraZeneca Plc Company Profile
- Novartis AG Company Profile
- Merck & Co. Inc.
- Pfizer Inc Company Profile
- Johnson & Johnson
- Bayer AG Company Profile
- Sanofi Company Profile
- GlaxoSmithKline (GSK)
- Boehringer Ingelheim
- AbbVie Inc. Company Profile
- Eli Lilly and Co.
- Bristol-Myers Squibb
- Roche Holding AG Company Profile
- Amgen Inc.
- Other key players
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible